Citadel Advisors’s SBC Medical Group SBC Stock Holding History

Citadel Advisors’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-29,366	Closed	-$136K	–	14445
2025 Q2	$136K	Buy	+29,366	New	+$116K	﹤0.01%	11050

Other funds holding SBC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors's SBC Position: Q3 2025 in Review

Citadel Advisors sold out of SBC Medical Group (SBC) in Q3 2025, closing a stake of 29,366 shares — an estimated $136K sold.

Citadel Advisors first reported a position in SBC in Q2 2025 and held it in 1 quarter. The position peaked at $136K in Q2 2025. 42 funds tracked by Wall St. Rank hold SBC as of Q3 2025.

Citadel Advisors reported no remaining SBC Medical Group position as of Q3 2025 after selling out during the quarter.
Citadel Advisors sold 29,366 SBC Medical Group shares in Q3 2025, an estimated $136K.
Citadel Advisors first reported a position in SBC Medical Group in Q2 2025 and held it in 1 quarter.
Citadel Advisors's SBC Medical Group position peaked at $136K in Q2 2025.
42 funds tracked by Wall St. Rank held SBC Medical Group as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.